Phorbol ester enhances deoxynucleoside incorporation while inhibiting proliferation of K-562 cells
Open Access
- 1 November 1985
- Vol. 6 (6), 591-596
- https://doi.org/10.1002/cyto.990060614
Abstract
Recently a new technique has been developed to study bromodeoxyuridine incorporation into DNA as a function of the cell cycle phase distribution. We have made the observation that treatment of the hematopoietic cell line K-562 results in a complete and immediate cessation of cell growth, althoughtritiated thymidine incorporation is markedly elevated for as long as 5 days. We have made use of that newly described technique to study this phenomenon.Keywords
This publication has 21 references indexed in Scilit:
- Significant non-S-phase DNA synthesis visualized by flow cytometry in activated and in malignant human lymphoid cellsExperimental Cell Research, 1985
- Expression of myeloid-specific antigens on two human erythroleukaemia cell lines, HEL and K562Leukemia Research, 1984
- Megakaryoblastic differentiation of proerythroblastic K562 cell-line cellsLeukemia Research, 1984
- Differentiation-associated changes in human non-T, non-B leukemia cell lines after treatment with 12-O-tetradecanoylphorbol 13-acetate (TPA)Leukemia Research, 1984
- Erythroid properties of K562 cells: Effect of hemin, butyrate and TPA inductionExperimental Cell Research, 1983
- Induction of Differentiation in a Case of Common Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1982
- Receptor-mediated Modulation of Human Monocyte, Neutrophil, Lymphocyte, and Platelet Function by Phorbol DiestersJCI Insight, 1982
- Induction of differentiation in human T-lymphoblastic leukemia cell lines by 12-O-tetradecanoylphorbol 13-acetate (TPA): Studies with monoclonal antibodies to T cellsCellular Immunology, 1982
- A Multipotential Leukemia Cell Line (K-562) of Human OriginExperimental Biology and Medicine, 1981
- Properties and usefulness of the original K-562 human myelogenous leukemia cell lineLeukemia Research, 1979